Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Scholar Rock Holding Corp (NQ: SRRK ) 9.100 +0.170 (+1.90%) Official Closing Price Updated: 4:15 PM EDT, Jul 12, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 633,820 Open 9.110 Bid (Size) 7.600 (1) Ask (Size) 9.580 (10) Prev. Close 8.930 Today's Range 8.800 - 9.420 52wk Range 5.930 - 21.17 Shares Outstanding 79,754,065 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 12, 2024 From Scholar Rock Via Business Wire Scholar Rock Announces New SRK-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist Withdrawal June 24, 2024 From Scholar Rock Via Business Wire Performance YTD -48.00% -48.00% 1 Month -3.50% -3.50% 3 Month -31.73% -31.73% 6 Month -42.80% -42.80% 1 Year +29.63% +29.63% More News Read More Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 18, 2024 From Scholar Rock Via Business Wire 12 Health Care Stocks Moving In Monday's After-Market Session June 03, 2024 Via Benzinga Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting June 03, 2024 From Scholar Rock Via Business Wire Scholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting May 28, 2024 From Scholar Rock Via Business Wire Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity May 22, 2024 From Scholar Rock Via Business Wire Scholar Rock to Participate in Upcoming Investor Conferences May 20, 2024 From Scholar Rock Via Business Wire Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 17, 2024 From Scholar Rock Via Business Wire Scholar Rock to Host Investor Day on May 22, 2024 May 14, 2024 From Scholar Rock Via Business Wire SRRK Stock Earnings: Scholar Rock Holding Misses EPS for Q1 2024 May 07, 2024 Via InvestorPlace Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress May 07, 2024 From Scholar Rock Via Business Wire 3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains April 24, 2024 Via InvestorPlace Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 12, 2024 From Scholar Rock Via Business Wire Scholar Rock Is A Potential M&A Target, Its Exploration of Obesity Market Garners Interest: Analyst March 28, 2024 Via Benzinga SRRK Stock Earnings: Scholar Rock Holding Misses EPS for Q4 2023 March 19, 2024 Via InvestorPlace Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress March 19, 2024 From Scholar Rock Via Business Wire Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 15, 2024 From Scholar Rock, Inc. Via Business Wire NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday March 05, 2024 Via Benzinga Topics Stocks Exposures US Equities Scholar Rock to Participate in Upcoming Investor Conferences February 28, 2024 From Scholar Rock Via Business Wire Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 16, 2024 From Scholar Rock Via Business Wire Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer February 15, 2024 From Scholar Rock Via Business Wire Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management February 06, 2024 From Scholar Rock Via Business Wire Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia January 25, 2024 From Scholar Rock Via Business Wire Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity January 23, 2024 From Scholar Rock Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.